Home » Topics » BioWorld Science

BioWorld Science
RSS

Entera initiates phase II dose ranging study for oral PTH

July 4, 2019

Phase II trial of axitinib plus pembrolizumab in patients with advanced sarcomas

July 4, 2019

ADAMTS13 deficiency contributes to Alzheimer's disease cerebrovascular dysfunction

July 4, 2019

Protein provides protection against diabetic retinopathy

July 4, 2019

Sirona's SGLT2 inhibitor TFC-039 advancing through phase I trials

July 4, 2019

Phase III trial of tucidinostat/exemestane in advanced, HR-positive breast cancer

July 4, 2019

Clinical qualification of a novel P2X7-specific PET ligand in healthy volunteers

July 4, 2019

Their antiviral work done, T cells go rogue

July 4, 2019

Algernon's NP-120 reduces fibrosis in in vivo animal model study of IPF

July 3, 2019

European Commission approves Dovato for HIV-1 infection

July 3, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 14, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 14, 2026.
ADCs’ breakout 2025 and their still-unfinished potential
BioWorld
Over the course of the year, and continuing into the latest scientific meetings, an extraordinary breadth of new antibody-drug conjugate (ADC) designs was...
LINC01116 has prognostic value in lung cancer, study shows
BioWorld MedTech
Long noncoding RNAs (lncRNAs) have emerged as potential markers of disease, since they associate with proteins that regulate gene expression, translation or...
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...